| Roger Blanchard, MSW, LCSW | |
|
101 E Pier St, Port Washington, WI 53074-1939 | |
| (262) 284-3117 | |
| (262) 284-3087 |
| Full Name | Roger Blanchard |
|---|---|
| Gender | Male |
| Speciality | Social Worker - Clinical |
| Location | 101 E Pier St, Port Washington, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073536793 | NPI | - | NPPES |
| 39299600 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 1045-123 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Roger Blanchard, MSW, LCSW 285 N Janacek Rd, Brookfield, WI 53045-6102 Ph: (262) 641-9050 | Roger Blanchard, MSW, LCSW 101 E Pier St, Port Washington, WI 53074-1939 Ph: (262) 284-3117 |
News Archive
A report released Thursday in Bangkok by the United Nations Development Programme (UNDP) and the Asia Pacific Transgender Network (APTN) says more research needs to be conducted to determine the extent to which transgender persons in Asia and the Pacific are affected by HIV, are socially ostracized, and lack fundamental rights, including access to basic health care, a UNDP press release reports.
A non-toxic and environmentally friendly way to make tiny nanorods of zinc oxide has been developed for the first time by researchers in Saudi Arabia. The approach, described in the current issue of the International Journal of Nanoparticles, could allow the nanorods to be used safely in medical and for other applications.
Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Eagle Eye® Platinum digital IVUS catheter in the United States.
Several vaccines have been rapidly developed to help control the COVID-19 pandemic, including the BNT162b2 vaccine (Pfizer/BioNTech). This severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine has been shown in both clinical trials and in the real world to be highly efficacious in preventing infection, symptoms, hospitalizations, severe disease, and death related to coronavirus disease (COVID-19).
› Verified 7 days ago
Renee M Keranen, MSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 121 W Main St, Port Washington, WI 53074 Phone: 262-284-8133 Fax: 262-284-8104 | |
Sandra Jacques, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 121 W Main St, Suite 350, Port Washington, WI 53074 Phone: 262-284-8130 Fax: 262-284-8104 | |
Mrs. Deanna Schultz-depies, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 121 W Main St, #350, Port Washington, WI 53074 Phone: 262-284-8140 Fax: 262-284-8104 | |
Timothy J Shininger, LCSW LMFT Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1317 W Grand Ave, Port Washington, WI 53074 Phone: 262-284-5789 Fax: 262-284-5907 | |
Sandra E Black, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1317 W Grand Ave, Port Washington, WI 53074 Phone: 262-284-5789 Fax: 262-284-5907 | |
Lorene Menchaca, LCSW, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 101 E Pier St, Port Washington, WI 53074 Phone: 262-284-3117 Fax: 262-284-3087 |